Políticas Médicas

Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.

Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.

Tabla de Políticas Médicas

ID Título Revisión Descripción Acceso
11.001.005 In Vitro Chemoresistance And Chemosensitivity Assays Jul 2025 In vitro chemoresistance and chemosensitivity assays have been developed to provide information about the... Ver
11.001.006 Prueba de aliento de urea en el diagnóstico Helicobacter Pylori Feb 2025 Several invasive and non-invasive tests are available for the detection of helicobacter pylori infection in... Ver
11.001.007 Identification Of Microorganisms Using Nucleic Acid Probes Sep 2026 Nucleic acid probes are available for the identification of a wide variety of microorganisms. nucleic acid... Ver
11.001.009 Noninvasine Techniques For The Evaluation And Monitoring Of Patients With Chronic Liver Disease Aug 2026 Noninvasive techniques to monitor liver fibrosis are being investigated as alternatives to liver biopsy in... Ver
11.001.010 Alfa-fetoproteina en la deteccion de cancer hepatocelular May 2016 ... Ver
11.001.011 Serum Biomarker Human Epididymis Protein 4 Jan 2026 Human epididymis protein 4 (he4) is a novel biomarker that has been cleared by the u.s. food and drug... Ver
11.001.012 Jak2 And Mpl, Testing For Myeloproliferative Neoplasms Sep 2026 Somatic (acquired) genetic variants in jak2, mpl, and calr genes have been implicated as the underlying... Ver
11.001.013 Urinary Biomarkers For Cancer Screening, Diagnosis, And Surveillance Jan 2026 The diagnosis of bladder cancer is generally made by cystoscopy and biopsy. bladder cancer has a very high... Ver
11.001.016 Serum Biomarker Tests For Multiple Sclerosis Jul 2025 Serum antibodies to polysaccharide-containing molecules, called glycans, and other serum biomarkers are... Ver
11.001.017 Pharmacogenetic Testing For Pain Management Feb 2026 While multiple pharmacologic therapies are available for the management of acute and chronic pain, there is a... Ver
11.001.020 Detection Of Circulating Tumor Cells In The Management Of Patients With Cancer May 2019 The prognosis of cancer patients is often determined by the occurrence of metastatic disease. studies have... Ver
11.001.022 Homocysteine Testing In The Screening, Diagnosis, And Management Of Cardiovascular Disease And Venous Thromboembolic Disease Jan 2026 Homocysteine is an amino acid that has been evaluated as a potential marker of cardiovascular disease (cvd)... Ver
11.001.023 Procalcitonin As A Marker In The Systemic Inflammatory Response Nov 2021 Severe infection and sepsis are frequent causes of morbidity and mortality in intensive care units. infection... Ver
11.001.026 Genotipo y Fenotipo en HIV May 2016 ... Ver
11.001.027 Immune Cell Function Assay Jan 2026 Careful monitoring of lifelong immunosuppression is required to ensure the long-term viability of solid organ... Ver
11.001.029 Prueba fibronectina fetal May 2016 ... Ver
11.001.032 Evaluation of Biomarkers for Alzheimer Disease Jun 2026 Biochemical changes associated with the pathophysiology of alzheimer disease (ad) are being evaluated to aid... Ver
11.001.033 Bone Turnover Markers For The Diagnosis And Management Of Osteoporosis And Diseases Associated With High Bone Turnover Jan 2026 Bone turnover markers are biochemical markers of either bone formation or bone resorption. commercially... Ver
11.001.034 Fecal Analysis In The Diagnosis Of Intestinal Dysbiosis Jan 2026 Intestinal dysbiosis may be defined as a state of disordered microbial ecology that is believed to cause... Ver
11.001.036 Quantitative Assay For Measurement Of Her2 Total Protein Expression And Her2 Jan 2021 Novel assays that quantitatively measure total human epidermal growth factor receptor 2 (her2) protein... Ver